Oct 27 (Reuters) – Cooper Companies said on Tuesday CEO Al White had stepped down, effective immediately, and board member Walt Rosebrough was elected executive chair as the medical device maker begins a search for a new CEO.
Shares of the California-based company fell nearly 3% in extended trading.
• Rosebrough, an independent director who joined the board in January and is the former CEO of STERIS, will oversee day-to-day operations until a permanent chief executive is appointed
• Rosebrough said recent performance “has not met our expectations” and warranted decisive action by the board
• White, who is also leaving the board, will remain with the company as a strategic adviser through April 2027
• Additionally, Shlomi Nachman, a former Johnson & Johnson executive with experience in medical devices and vision care, will join the board as an independent director, effective December 8, Cooper said
• Three current board members, Barbara Carbone, Colleen Jay and Robert Weiss, will not stand for re-election at the company’s 2027 annual shareholder meeting, it added
• The company reaffirmed its fiscal 2026 forecast issued on September 9, including annual adjusted earnings of $4.51 to $4.55 per share
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shreya Biswas)
